Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 14Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Myelodysplastic Syndromes 12Lymphoma, Non-Hodgkin 11Hodgkin Disease 11Leukemia, Lymphocytic, Chronic, B-Cell 10Leukemia 10Multiple Myeloma 9Leukemia, Myelomonocytic, Chronic 9Leukemia, Myeloid, Accelerated Phase 9Lymphoma, Mantle-Cell 8Leukemia, Myeloid, Chronic-Phase 8Hematologic Neoplasms 8Lymphoma, Large B-Cell, Diffuse 7Lymphoma, Follicular 7Lymphoma 7Myeloproliferative Disorders 6Lymphoma, B-Cell, Marginal Zone 6Leukemia, Biphenotypic, Acute 6Graft vs Host Disease 6Congenital Abnormalities 6Blast Crisis 6Waldenstrom Macroglobulinemia 5Lymphoma, Large-Cell, Immunoblastic 5Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5Carcinoma, Renal Cell 5Burkitt Lymphoma 5Anemia, Refractory, with Excess of Blasts 5Lymphoma, T-Cell, Cutaneous 4Recurrence 3

Interventions

fludarabine 1Whole-Body Irradiation 1Tacrolimus 1Stem Cell Transplantation 1Rituximab 1Mycophenolic Acid 1Melphalan 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Cyclophosphamide 1CT-P10 1Bendamustine Hydrochloride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Hematopoietic and Lymphoid System Neoplasm × Mycophenolic Acid × Clear all
NCT04022239 2026-01-12

Bendamustine With or Without Cyclophosphamide in Preventing GVHD in Patients Undergoing Stem Cell Transplant

M.D. Anderson Cancer Center

Phase 1/2 Recruiting
25 enrolled

Hematopoietic and Lymphoid System Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡